GH and IGFs

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 97 | ESPE2023 | Next issue

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sept 2023 - 23 Sept 2023

The 61st ESPE Annual Meeting will now be taking place in The Hague, The Netherlands

Free Communications

Previous section
Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders

Table of contents

Next section
Thyroid

hrp0097fc11.1 | GH and IGFs

GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4

hrp0097fc11.2 | GH and IGFs

Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data

hrp0097fc11.3 | GH and IGFs

Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations

hrp0097fc11.4 | GH and IGFs

Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls

hrp0097fc11.5 | GH and IGFs

Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

hrp0097fc11.6 | GH and IGFs

Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy.

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts